Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Schrodinger Inc SDGR

Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its... see more

Recent & Breaking News (NDAQ:SDGR)

Schrödinger to Announce Third Quarter 2023 Financial Results on November 1

Business Wire October 18, 2023

Schrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling Education

Business Wire September 28, 2023

Qiming Venture Partners' portfolio company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange

PR Newswire September 26, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 18, 2023

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Business Wire September 5, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 11, 2023

Schrödinger Reports Second Quarter 2023 Financial Results

Business Wire August 2, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire July 20, 2023

Schrödinger to Announce Second Quarter 2023 Financial Results on August 2

Business Wire July 19, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire June 22, 2023

Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Business Wire June 1, 2023

Schrödinger to Present at Jefferies Global Biopharma Conference

Business Wire May 26, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire May 25, 2023

Schrödinger Reports Strong First Quarter 2023 Financial Results

Business Wire May 4, 2023

Schrödinger Publishes Inaugural Corporate Sustainability Report

Business Wire April 27, 2023

Schrödinger to Announce First Quarter 2023 Financial Results on May 4

Business Wire April 20, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire April 19, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire March 22, 2023

Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results

Business Wire February 28, 2023

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire February 17, 2023